| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -5.1e-05 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |